These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 25844527)

  • 21. Expanding treatment capacity for opioid dependence with office-based treatment with buprenorphine: National surveys of physicians.
    Arfken CL; Johanson CE; di Menza S; Schuster CR
    J Subst Abuse Treat; 2010 Sep; 39(2):96-104. PubMed ID: 20598829
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparing Buprenorphine-Prescribing Physicians Across Nonmetropolitan and Metropolitan Areas in the United States.
    Lin LA; Knudsen HK
    Ann Fam Med; 2019 May; 17(3):212-220. PubMed ID: 31085525
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The expert consensus guideline series. Optimizing pharmacologic treatment of psychotic disorders. Introduction: methods, commentary, and summary.
    Kane JM; Leucht S; Carpenter D; Docherty JP;
    J Clin Psychiatry; 2003; 64 Suppl 12():5-19. PubMed ID: 14640142
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Providing Incentive for Emergency Physician X-Waiver Training: An Evaluation of Program Success and Postintervention Buprenorphine Prescribing.
    Foster SD; Lee K; Edwards C; Pelullo AP; Khatri UG; Lowenstein M; Perrone J
    Ann Emerg Med; 2020 Aug; 76(2):206-214. PubMed ID: 32376089
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Feasibility of Implementing Shared Medical Appointments (SMAs) for Office-Based Opioid Treatment With Buprenorphine: A Pilot Study.
    Suzuki J; Zinser J; Klaiber B; Hannon M; Grassi H; Spinosa M; Ramirez A; Issa M; Chin Feman SP
    Subst Abus; 2015; 36(2):166-9. PubMed ID: 25738320
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of transdermal buprenorphine in the treatment of cancer pain: an expert panel consensus.
    Pergolizzi JV; Mercadante S; Echaburu AV; Van den Eynden B; Fragoso RM; Mordarski S; Lybaert W; Beniak J; OroĊ„ska A; Slama O;
    Curr Med Res Opin; 2009 Jun; 25(6):1517-28. PubMed ID: 19435402
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A qualitative study of the adoption of buprenorphine for opioid addiction treatment.
    Green CA; McCarty D; Mertens J; Lynch FL; Hilde A; Firemark A; Weisner CM; Pating D; Anderson BM
    J Subst Abuse Treat; 2014 Mar; 46(3):390-401. PubMed ID: 24268947
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Determinants of buprenorphine treatment for opioid dependence.
    Murphy SM; Fishman PA; McPherson S; Dyck DG; Roll JR
    J Subst Abuse Treat; 2014 Mar; 46(3):315-9. PubMed ID: 24209382
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analysis of barriers to adoption of buprenorphine maintenance therapy by family physicians.
    DeFlavio JR; Rolin SA; Nordstrom BR; Kazal LA
    Rural Remote Health; 2015; 15():3019. PubMed ID: 25651434
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Buprenorphine and methadone for opioid addiction during pregnancy.
    Mozurkewich EL; Rayburn WF
    Obstet Gynecol Clin North Am; 2014 Jun; 41(2):241-53. PubMed ID: 24845488
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Steps physicians report taking to reduce diversion of buprenorphine.
    Yang A; Arfken CL; Johanson CE
    Am J Addict; 2013; 22(3):184-7. PubMed ID: 23617857
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expanded buprenorphine prescribing privileges: Sandbagging in the midst of the flood?
    Brown JD; Nolte JL
    Res Social Adm Pharm; 2018 Jun; 14(6):617-618. PubMed ID: 29525482
    [No Abstract]   [Full Text] [Related]  

  • 33. From methadone to buprenorphine: changes during a 10 year period within a national opioid maintenance treatment programme.
    Riksheim M; Gossop M; Clausen T
    J Subst Abuse Treat; 2014 Mar; 46(3):291-4. PubMed ID: 24210532
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Buprenorphine in maintenance treatment: experience among Italian physicians in drug addiction centers.
    Quaglio G; Pattaro C; Gerra G; Mezzelani P; Montanari L; Jarlais DC; Lugoboni F
    Am J Addict; 2010; 19(3):222-30. PubMed ID: 20525028
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Training HIV physicians to prescribe buprenorphine for opioid dependence.
    Sullivan LE; Tetrault J; Bangalore D; Fiellin DA
    Subst Abus; 2006 Sep; 27(3):13-8. PubMed ID: 17135176
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Office-based buprenorphine treatment for opioid-dependent patients.
    McCance-Katz EF
    Harv Rev Psychiatry; 2004; 12(6):321-38. PubMed ID: 15764468
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Methadone and buprenorphine for opioid dependence during pregnancy: a retrospective cohort study.
    Meyer MC; Johnston AM; Crocker AM; Heil SH
    J Addict Med; 2015; 9(2):81-6. PubMed ID: 25622120
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Outcomes of DATA 2000 certification trainings for the provision of buprenorphine treatment in the Veterans Health Administration.
    Gordon AJ; Liberto J; Granda S; Salmon-Cox S; Andree T; McNicholas L
    Am J Addict; 2008; 17(6):459-62. PubMed ID: 19034736
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Where Is Buprenorphine Dispensed to Treat Opioid Use Disorders? The Role of Private Offices, Opioid Treatment Programs, and Substance Abuse Treatment Facilities in Urban and Rural Counties.
    Stein BD; Pacula RL; Gordon AJ; Burns RM; Leslie DL; Sorbero MJ; Bauhoff S; Mandell TW; Dick AW
    Milbank Q; 2015 Sep; 93(3):561-83. PubMed ID: 26350930
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of pain in patients taking buprenorphine for opioid addiction #221.
    Childers JW; Arnold RM
    J Palliat Med; 2012 May; 15(5):613-4. PubMed ID: 22577788
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.